PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.75%
Revenue growth under 50% of 9843.T's 24.52%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.77%
Gross profit growth under 50% of 9843.T's 26.85%. Michael Burry would be concerned about a severe competitive disadvantage.
4.04%
EBIT growth below 50% of 9843.T's 99.62%. Michael Burry would suspect deeper competitive or cost structure issues.
15.41%
Operating income growth under 50% of 9843.T's 92.31%. Michael Burry would be concerned about deeper cost or sales issues.
13.61%
Net income growth under 50% of 9843.T's 101.53%. Michael Burry would suspect the firm is falling well behind a key competitor.
13.59%
EPS growth under 50% of 9843.T's 101.53%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
13.59%
Diluted EPS growth under 50% of 9843.T's 101.53%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.02%
Slight or no buybacks while 9843.T is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.02%
Slight or no buyback while 9843.T is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-100.00%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
160.73%
Similar 10Y revenue/share CAGR to 9843.T's 147.70%. Walter Schloss might see both firms benefiting from the same long-term demand.
56.92%
5Y revenue/share CAGR at 75-90% of 9843.T's 66.68%. Bill Ackman would encourage strategies to match competitor’s pace.
34.46%
3Y revenue/share CAGR at 75-90% of 9843.T's 38.76%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
138.65%
Net income/share CAGR at 50-75% of 9843.T's 186.67%. Martin Whitman might question if the firm’s product or cost base lags behind.
37.21%
Below 50% of 9843.T's 114.89%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-32.24%
Negative 3Y CAGR while 9843.T is 12.92%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
331.44%
10Y equity/share CAGR 1.25-1.5x 9843.T's 261.90%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
86.25%
5Y equity/share CAGR is in line with 9843.T's 80.01%. Walter Schloss would see parallel mid-term profitability and retention policies.
35.83%
3Y equity/share CAGR at 75-90% of 9843.T's 40.30%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
166.67%
Dividend/share CAGR of 166.67% while 9843.T is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
No Data
No Data available this quarter, please select a different quarter.
9.04%
AR growth is negative/stable vs. 9843.T's 38.83%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-3.29%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.36%
Negative asset growth while 9843.T invests at 3.51%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.52%
50-75% of 9843.T's 2.68%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-6.02%
We’re deleveraging while 9843.T stands at 27.64%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-0.62%
We cut SG&A while 9843.T invests at 8.34%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.